{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:05Z","timestamp":1792784825863,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Drager Medical, Timpel, Smiths Medical, Aerogen, VERO-Biotech, Philips\/Respironics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1038\/s41372-021-00924-y","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T08:11:29Z","timestamp":1611821489000},"page":"779-785","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The association between diuretic class exposures and enteral electrolyte use in infants developing grade 2 or 3 bronchopulmonary dysplasia in United States children\u2019s hospitals"],"prefix":"10.1038","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7435-2610","authenticated-orcid":false,"given":"Timothy D.","family":"Nelin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lorch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stamatia","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1498-8465","authenticated-orcid":false,"given":"Natalie","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather M.","family":"Monk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Shults","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6427-093X","authenticated-orcid":false,"given":"Nicolas A.","family":"Bamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"924_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","volume":"289","author":"B Schmidt","year":"2003","unstructured":"Schmidt B, Asztalos EV, Roberts RS, Robertson CMT, Sauve RS, Whitfield MF. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. J Am Med Assoc.2003;289:1124\u20139. https:\/\/doi.org\/10.1001\/jama.289.9.1124.","journal-title":"J Am Med Assoc."},{"key":"924_CR2","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/14767058.2016.1235696","volume":"30","author":"M Kurek Eken","year":"2017","unstructured":"Kurek Eken M, T\u00fcten A, \u00d6zkaya E, Karatekin G, Karateke A. Major determinants of survival and length of stay in the neonatal intensive care unit of newborns from women with premature preterm rupture of membranes. J Matern Neonatal Med. 2017;30:1972\u20135. https:\/\/doi.org\/10.1080\/14767058.2016.1235696.","journal-title":"J Matern Neonatal Med"},{"key":"924_CR3","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1001\/jamapediatrics.2014.3351","volume":"169","author":"PY Ancel","year":"2015","unstructured":"Ancel PY, Goffinet F, the EPIPAGE-2 Writing Group. Survival and morbidity of preterm children born at 22 through 34weeks\u2019 gestation in france in 2011 results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015;169:230\u20138. https:\/\/doi.org\/10.1001\/jamapediatrics.2014.3351.","journal-title":"JAMA Pediatr"},{"key":"924_CR4","doi-asserted-by":"publisher","unstructured":"Stroustrup A, Trasande L. Epidemiological characteristics and resource use in neonates with bronchopulmonary dysplasia: 1993-2006. Pediatrics. 2010. https:\/\/doi.org\/10.1542\/peds.2009-3456.","DOI":"10.1542\/peds.2009-3456"},{"key":"924_CR5","doi-asserted-by":"publisher","unstructured":"Van Marter LJ. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009. https:\/\/doi.org\/10.1016\/j.siny.2009.08.007.","DOI":"10.1016\/j.siny.2009.08.007"},{"key":"924_CR6","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1001\/jama.2015.10244","volume":"314","author":"BJ Stoll","year":"2015","unstructured":"Stoll BJ, Hansen NI, Bell EF, Walsh MC, Carlo WA, Shankaran S, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993\u20132012. JAMA. 2015;314:1039\u201351. https:\/\/doi.org\/10.1001\/jama.2015.10244.","journal-title":"JAMA"},{"key":"924_CR7","doi-asserted-by":"publisher","unstructured":"Jobe AH, Bancalari E. Broncopulmonary dysplasia. Am J Respir Crit Care Med. 2001. https:\/\/doi.org\/10.1164\/ajrccm.163.7.2011060.","DOI":"10.1164\/ajrccm.163.7.2011060"},{"key":"924_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpeds.2016.10.082","volume":"181","author":"SH Abman","year":"2017","unstructured":"Abman SH, Collaco JM, Shepherd EG, Keszler M, Cuevas-Guaman M, Welty SE, et al. Bronchopulmonary Dysplasia Collaborative. Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. J Pediatr. 2017;181:12-28.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.10.082.","journal-title":"J Pediatr"},{"key":"924_CR9","doi-asserted-by":"publisher","unstructured":"Mandell EW, Kratimenos P, Abman SH, Steinhorn RH. Drugs for the prevention and treatment of bronchopulmonary dysplasia. Clin Perinatol. 2019;46. https:\/\/doi.org\/10.1016\/j.clp.2019.02.011.","DOI":"10.1016\/j.clp.2019.02.011"},{"key":"924_CR10","doi-asserted-by":"publisher","unstructured":"Laughon MM, Chantala K, Aliaga S, Herring AH, Hornik CP, Hughes R. et al. Diuretic exposure in premature infants from 1997 to 2011. Am J Perinatol. 2015. https:\/\/doi.org\/10.1055\/s-0034-1373845.","DOI":"10.1055\/s-0034-1373845"},{"key":"924_CR11","doi-asserted-by":"publisher","unstructured":"Bamat NA, Kirpalani H, Feudtner C, Jensen EA, Laughon MM, Zhang H. et al. Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children\u2019s hospitals. J Perinatol. 2019. https:\/\/doi.org\/10.1038\/s41372-019-0415-9.","DOI":"10.1038\/s41372-019-0415-9"},{"key":"924_CR12","doi-asserted-by":"publisher","unstructured":"Cuevas Guaman M, Gien J, Baker CD, Zhang H, Austin ED, Collaco JM. Point prevalence, clinical characteristics, and treatment variation for infants with severe bronchopulmonary dysplasia. Am J Perinatol. 2015. https:\/\/doi.org\/10.1055\/s-0035-1547326.","DOI":"10.1055\/s-0035-1547326"},{"key":"924_CR13","doi-asserted-by":"publisher","unstructured":"Stewart A, Brion LP Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database of Systematic Reviews. 2011. https:\/\/doi.org\/10.1002\/14651858.CD001453.pub2.","DOI":"10.1002\/14651858.CD001453.pub2"},{"key":"924_CR14","doi-asserted-by":"publisher","unstructured":"Stewart A, Brion LP, Ambrosio-Perez I. Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database of Systematic Reviews. 2011. https:\/\/doi.org\/10.1002\/14651858.CD001817.pub2.","DOI":"10.1002\/14651858.CD001817.pub2"},{"key":"924_CR15","doi-asserted-by":"publisher","unstructured":"Albersheim SG, Solimano AJ, Sharma AK, Smyth JA, Rotschild A, Wood BJ. et al. Randomized, double-blind, controlled trial of long-term diuretic therapy for bronchopulmonary dysplasia. J Pediatr. 1989. https:\/\/doi.org\/10.1016\/S0022-3476(89)80297-5.","DOI":"10.1016\/S0022-3476(89)80297-5"},{"key":"924_CR16","doi-asserted-by":"publisher","unstructured":"Atkinson SA, Shah JK, McGee C, Steele BT. Mineral excretion in premature infants receiving various diuretic therapies. J Pediatr. 1988. https:\/\/doi.org\/10.1016\/S0022-3476(88)80648-6.","DOI":"10.1016\/S0022-3476(88)80648-6"},{"key":"924_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0022-3476(78)80098-5.","volume":"92","author":"BS Ross","year":"1978","unstructured":"Ross BS, Pollak A, Oh W. The pharmacologic effects of furosemide therapy in the low-birth-weight infant. J Pediatr. 1978;92:149\u201352. https:\/\/doi.org\/10.1016\/S0022-3476(78)80098-5.","journal-title":"J Pediatr"},{"key":"924_CR18","unstructured":"Rang HP. Rang and Dale\u2019s Pharmacology; 2016."},{"key":"924_CR19","doi-asserted-by":"publisher","unstructured":"Slaughter JL, Stenger MR, Reagan PB. Variation in the use of diuretic therapy for infants with bronchopulmonary dysplasia. Pediatrics. 2013. https:\/\/doi.org\/10.1542\/peds.2012-1835.","DOI":"10.1542\/peds.2012-1835"},{"key":"924_CR20","doi-asserted-by":"publisher","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M. et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants an evidence-based approach. Am J Respir Crit Care Med. 2019. https:\/\/doi.org\/10.1164\/rccm.201812-2348OC.","DOI":"10.1164\/rccm.201812-2348OC"},{"key":"924_CR21","doi-asserted-by":"publisher","unstructured":"Williams R. Using the margins command to estimate and interpret adjusted predictions and marginal effects. Stata J. 2012. https:\/\/doi.org\/10.1177\/1536867x1201200209.","DOI":"10.1177\/1536867x1201200209"},{"key":"924_CR22","doi-asserted-by":"publisher","unstructured":"Hoffman DJ, Gerdes JS, Abbasi S. Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled, randomized trial. J Perinatol. 2000. https:\/\/doi.org\/10.1038\/sj.jp.7200307.","DOI":"10.1038\/sj.jp.7200307"},{"key":"924_CR23","doi-asserted-by":"publisher","unstructured":"Moffett BS, Haworth TE, Wang Y, Afonso N, Checchia PA. Spironolactone effect on potassium supplementation in paediatric cardiac intensive care patients. J Clin Pharm Ther. 2017. https:\/\/doi.org\/10.1111\/jcpt.12525.","DOI":"10.1111\/jcpt.12525"},{"key":"924_CR24","doi-asserted-by":"publisher","unstructured":"Dartois LL, Levek C, Grover TR, Murphy ME, Ross EL. Diuretic use and subsequent electrolyte supplementation in a level IV neonatal intensive care unit. J Pediatr Pharmacol Ther. 2020. https:\/\/doi.org\/10.5863\/1551-6776-25.2.124.","DOI":"10.5863\/1551-6776-25.2.124"},{"key":"924_CR25","doi-asserted-by":"publisher","first-page":"e123","DOI":"10.1097\/MPG.0000000000001294.","volume":"63","author":"AR Bischoff","year":"2016","unstructured":"Bischoff AR, Tomlinson C, Belik J. Sodium intake requirements for preterm neonates. J Pediatr Gastroenterol Nutr. 2016;63:e123\u2013e129. https:\/\/doi.org\/10.1097\/MPG.0000000000001294.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"924_CR26","doi-asserted-by":"publisher","unstructured":"Kielt MJ, Ferrara M, Shepherd EG. Striving to be better: medication overexposure among infants with severe BPD. J Perinatol. 2019. https:\/\/doi.org\/10.1038\/s41372-019-0459-x.","DOI":"10.1038\/s41372-019-0459-x"},{"key":"924_CR27","doi-asserted-by":"publisher","unstructured":"Wang LA, Smith PB, Laughon M, Goldberg RN, Ku LC, Zimmerman KO. et al. Prolonged furosemide exposure and risk of abnormal newborn hearing screen in premature infants. Early Hum Dev. 2018. https:\/\/doi.org\/10.1016\/j.earlhumdev.2018.08.009.","DOI":"10.1016\/j.earlhumdev.2018.08.009"},{"key":"924_CR28","doi-asserted-by":"publisher","unstructured":"Buck ML. Clinical experience with spironolactone in pediatrics. Ann Pharmacother. 2005. https:\/\/doi.org\/10.1345\/aph.1E618.","DOI":"10.1345\/aph.1E618"},{"key":"924_CR29","doi-asserted-by":"publisher","unstructured":"Segar JL. Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol. 2012. https:\/\/doi.org\/10.1016\/j.clp.2011.12.007.","DOI":"10.1016\/j.clp.2011.12.007"},{"key":"924_CR30","doi-asserted-by":"crossref","unstructured":"Kao LC, Warburton D, Cheng MH, Cede\u00f1o C, Platzker AC, Keens TG. Effect of oral diuretics on pulmonary mechanics in infants with chronic bronchopulmonary dysplasia: results of a double-blind crossover sequential trial. Pediatrics. 1984;74:37\u201344.","DOI":"10.1542\/peds.74.1.37"},{"key":"924_CR31","doi-asserted-by":"publisher","unstructured":"Kao LC, Durand DJ, McCrea RC, Birch M, Powers RJ, Nickerson BG Randomized trial of long-term diuretic therapy for infants with oxygen-dependent bronchopulmonary dysplasia. J Pediatr. 1994. https:\/\/doi.org\/10.1016\/S0022-3476(05)81373-3.","DOI":"10.1016\/S0022-3476(05)81373-3"},{"key":"924_CR32","doi-asserted-by":"publisher","unstructured":"Chang HY, Hsu CH, Tsai JD, et al. Renal calcification in very low birth weight infants. Pediatr Neonatol. 2011. https:\/\/doi.org\/10.1016\/j.pedneo.2011.03.004.","DOI":"10.1016\/j.pedneo.2011.03.004"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-021-00924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-021-00924-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-021-00924-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:31:50Z","timestamp":1684603910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-021-00924-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["924"],"URL":"https:\/\/doi.org\/10.1038\/s41372-021-00924-y","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"29 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Mrs. Napolitano has research\/consulting relationships with Dr\u00e4ger Medical, Timpel, Smiths Medical, Aerogen, VERO-Biotech, and Philips\/Respironics. The remaining authors have no financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}